Gene Therapy Types In Healthcare

Medindia On Mobile

About Us Portfolio Press Careers Sitemap Advertise Contact Us Make this your Homepage

Custom Search

Register

Sign In

Sign In Using Facebook

Medindia » e-Publications / Medical Article » Gene Therapy » Types of Genes Therapy

Gene Therapy

	About Gene therapy
	What are the genes?
	How does gene therapy work?
	Types of gene therapy
	Viral gene delivery systems
	Non-viral gene delivery systems
	Pro-drug activation therapy
	Two-gene therapy
	Nucleic acid therapeutic agents
	Antisense RNA production
	Antisense Oligonucleotides
	Nucleic acid pharmaceuticals
	Ribozymes - as therapeutic agents
	Oligonucleotide correction of genetic
	History of events - gene therapy

	e-Publications
e-Health / Telemedicine Organ Donation / Transplantation Cancer Diseases Respiratory Medicine Endocrine Pharmacology Surgical Eye Urology Infection Auto-Immune Disease Tobacco Cardiology / Heart Diseases Genetics Stem Cell Research and Treatment

Medical Focus

Patient

Doctor

Student

Gene Therapy Introduction

page 1

Types of gene therapy

There are two forms of gene therapy – Somatic gene therapy and Germ line gene therapy.

Somatic gene therapy involves the manipulation of gene expression in cells that will be corrective to the patient but not inherited to the next generation. Somatic cell gene therapy is at an early stage of development.
Germ line gene therapy involves the genetic modification of germ cells (sperms and eggs) in order to prevent a genetic defect from being transmitted to future generations.

Various strategies involved in somatic cell gene therapy are emerging and can be grouped under two broad categories as ex vivo and in vivo gene therapy:

Ex vivo gene therapy:

. Ex vivo gene therapy involves following procedure:

	1.	Cells are collected from the affected individual.
	2.	The genetic defect is corrected by transferring the genes into the isolated cells.
	3.	The genetically corrected cells are selected and grown.
	4.	The genetically modified cells are transferred into the patient.
	5.	The use of patients’ owns cells (autologous cells) have no adverse immunological response after transplantation.
	6.	Vectors derived from mouse retroviruses are mostly used.
	7.	Intact particles deliver the complete vector RNA to a host cell at a high frequency.
	8.	Retroviruses readily infect replicating cells, so activelyh growing target cells are either treated with purified packaged retroviral vector particles directly or co cultivated with packaging cell line.
.	The transferred target cells are tested to ensure that:
	1.	The desired gene product is produced in the gene transferred humans.
	2.	It is ensured that the virus does not produce its pathogenic viral cellular structures and causes infection in the human host.
	3.	It is ensured that the Retroviral vector DNA has not been inserted into a size that either alters the growth properties of the cells or interferes with normal cellular functions.

Pages 1 2 Page 1

Print
Email

Related Links

Gene Therapy Treatment

Genetic Counseling

Consumers

Medical Professionals

Medical Students

Directories